Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hour.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Bristol Myers Squibb.

Advances In™ MDS and MPNs: Nursing Strategies for Disease and Anemia Management

Release Date: June 30, 2020
Expiration Date: June 30, 2021

Activity Overview

This online educational activity is designed to provide expert interpretation of new and emerging data on the treatment of myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPNs) with a focus on nursing strategies in the management of anemia associated with MDS and MPN. Topics include the latest data from clinical trials evaluating the use of therapies for MDS and MPN disease and symptom management, providing a forward-looking perspective on how novel agents may impact clinical practice. Signs and symptoms, current and emerging treatments, and quality of life considerations will be presented in a multimedia format, including a series of video interviews with two expert thought leaders integrated into text-based elements.

Acknowledgment of Commercial Support

This activity is supported by educational grants from Bristol Myers Squibb.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This activity is directed toward nurses involved in the treatment and management of myeloproliferative neoplasms (MPN) and myelodysplastic syndrome (MDS).

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • Review mechanisms of action of pathogenesis in MDS and MPN in relation to symptom burden including anemia.
  • Identify the role of novel therapeutics in development for the treatment of MDS and MPN.
  • Assess methods to improve quality of life with supportive care and therapeutic options for patients with MDS and MPN.
  • Integrate emerging data and best available evidence into patient counseling strategies to optimize care for patients with MDS and MPN.

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Lindsey Lyle, MS, PA-C
Lindsey Lyle, MS, PA-C
Senior Instructor
Blood Disorders Center
University of Colorado Anschutz Medical Campus
Aurora, CO

Disclosures: Spousal Employment: Business Director for Incyte. Consultant: Celegen, Incyte.

Mayra Lee, RN
Mayra Lee, RN
Moffitt Cancer Center
Tampa, FL

Disclosures: Mayra Lee, RN has no relevant financial relationships with commercial interests.

The staff Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By